Literature DB >> 12357062

Standards and guidelines for performing central dual X-ray densitometry from the Canadian panel of International Society for Clinical Densitometry.

A A Khan1, J Brown, K Faulkner, D Kendler, B Lentle, W Leslie, P D Miller, L Nicholson, W P Olszynski, N B Watts, D Hanley, A Hodsman, R Josse, T M Murray, K Yuen.   

Abstract

The International Society for Clinical Densitometry (ISCD) is a multidisciplinary nonprofit global organization formed to ensure excellence in densitometry imaging, interpretation, and application. The Canadian panel of the ISCD represents ISCD in Canada and oversees Canadian bone densitometry certification programs. The standards of care from the Canadian panel of the ISCD have been developed in order to establish the minimum level of acceptable performance for the practice of bone densitometry in Canada. A variety of techniques are available for skeletal assessment of bone mineral density, which vary in accuracy, precision, and clinical utility as well as availability. This article focuses on central dual X-ray absorptiometry in adults and does not address densitometry in the pediatric population. Other technologies will be addressed in a subsequent article.

Entities:  

Mesh:

Year:  2002        PMID: 12357062     DOI: 10.1385/jcd:5:3:247

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  3 in total

1.  The 2002 Canadian bone densitometry recommendations: take-home messages.

Authors:  Aliya A Khan; Jacques P Brown; David L Kendler; William D Leslie; Brian C Lentle; E Michael Lewiecki; Paul D Miller; R Lawrence Nicholson; Wojciech P Olszynski; Nelson B Watts
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

Review 2.  [Absorptiometry].

Authors:  S Prevrhal
Journal:  Radiologe       Date:  2006-10       Impact factor: 0.635

Review 3.  Review of guidelines for testing and treatment of osteoporosis.

Authors:  Piet P M M Geusens
Journal:  Curr Osteoporos Rep       Date:  2003-09       Impact factor: 5.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.